Altered proliferative and metastatic potential associated with increased expression of syndecan-1

被引:33
|
作者
Hirabayashi, K
Numa, F
Suminami, Y
Murakami, A
Murakami, T
Kato, H
机构
[1] Yamaguchi Univ, Sch Med, Dept Obstet & Gynecol, Ube, Yamaguchi 755, Japan
[2] Yamaguchi Univ, Sch Med, Dept Pathol 2, Ube, Yamaguchi 755, Japan
关键词
syndecan-1; cell growth; antisense oligodeoxynucleotides; tumorigenicity; intravasation;
D O I
10.1159/000030037
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The process of metastasis involves a series of sequential steps in which malignant cells are released from the primary tumor and metastasize to distant sites, Syndecan-1 is a cell surface proteoglycan that mediates cell adhesion and undergoes changes upon cell transformation of some cells that may contribute to the process of metastasis. To investigate the possible role of syndecan-1 in cell proliferation and metastatic potential, we employed a highly metastatic cell line (KLN 205) derived from mouse lung squamous cell carcinoma that expressed moderate amounts of syndecan-1, At first, endogenous syndecan-1 production was inhibited by an antisense oligodeoxynucleotides (ODNs). Since antisense ODNs of syndecan-1 inhibited cell growth, we established stable transfectants of syndecan-1 in this cell line to examine a proliferative advantage with the level of syndecan-1 expression, Overexpresser cells grew at a significantly faster rate than the vector-transfected control and showed greater incidence of tumor formation when injected subcutaneously into nude mice, Surprisingly, overexpresser cells enhanced pulmonary metastasis when injected intravenously, These results indicate that syndecan-1 expression plays a role in the control of cell proliferation and suggest that syndecan-1 expression may be involved in facilitating distant metastasis of tumor cells once they managed to enter the bloodstream (after intravasation steps).
引用
收藏
页码:454 / 463
页数:10
相关论文
共 50 条
  • [1] Altered expression of syndecan-1 in prostate cancer
    Kiviniemi, J
    Kallajoki, K
    Kujala, I
    Matikainen, MT
    Alanen, K
    Jalkanen, M
    Salmivirta, M
    APMIS, 2004, 112 (02) : 89 - 97
  • [2] Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential
    Matsumoto, A
    Ono, M
    Fujimoto, Y
    Gallo, RL
    Bernfield, M
    Kohgo, Y
    INTERNATIONAL JOURNAL OF CANCER, 1997, 74 (05) : 482 - 491
  • [3] Loss of expression of Syndecan-1 is associated with Tumor Recurrence, Metastatic Potential, and Poor Survival in patients with Colorectal carcinoma
    Al-Maghrabi, Jaudah
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2021, 37 (01) : 114 - 120
  • [4] Syndecan-1 expression in locally invasive and metastatic prostate cancer
    Chen, D
    Adenekan, B
    Chen, L
    Vaughan, ED
    Gerald, W
    Feng, ZD
    Knudsen, BS
    UROLOGY, 2004, 63 (02) : 402 - 407
  • [5] Syndecan-1 expression in locally invasive and metastatic prostate cancer
    Chen, DYT
    Adenekan, B
    Chen, L
    Vaughan, ED
    Gerald, WL
    Feng, ZD
    Knudsen, BS
    JOURNAL OF UROLOGY, 2004, 171 (04): : 293 - 293
  • [6] Acantholysis and spongiosis are associated with loss of syndecan-1 expression
    Bayer-Garner, IB
    Dilday, BR
    Sanderson, RD
    Smoller, BR
    JOURNAL OF CUTANEOUS PATHOLOGY, 2001, 28 (03) : 135 - 139
  • [7] Reduced expression of syndecan-1 affects metastatic potential and clinical outcome in patients with colorectal cancer
    Fujiya, M
    Watari, J
    Ashida, T
    Honda, M
    Tanabe, H
    Fujiki, T
    Saitoh, Y
    Kohgo, Y
    JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (10): : 1074 - 1081
  • [8] Loss of syndecan-1 and increased expression of heparanase in invasive esophageal carcinomas
    Mikami, S
    Ohashi, K
    Usui, Y
    Nemoto, T
    Katsube, K
    Yanagishita, M
    Nakajima, M
    Nakamura, K
    Koike, M
    JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (10): : 1062 - 1073
  • [9] Acantholysis and spongiosis are associated with loss of syndecan-1 expression.
    Dilday, B
    Bayer-Garner, I
    Sanderson, R
    Smoller, B
    LABORATORY INVESTIGATION, 1999, 79 (01) : 56A - 56A
  • [10] Reduction of syndecan-1 expression is associated with dysplastic oral epithelium
    Soukka, T
    Pohjola, J
    Inki, P
    Happonen, RP
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 2000, 29 (07) : 308 - 313